Cuban biotechnology drugs reinforce preventive health strategies in the province of Cienfuegos in the face of the re-outbreak of COVID-19 in the territory, among those with the highest incidence of the disease in the country.
Maria Guadalupe Guzman, director of research, diagnosis and reference of the Pedro Kouri Institute of Tropical Medicine, said on Monday 16, that the Delta variant of SARS-CoV-2 is the one that currently predominates in Cuba.
The first secretary of the Central Committee of Cuban Communist Party and President of the Republic, Miguel Diaz-Canel, called the attention on Wednesday 21, about a new protocol for COVID-19 patients care.
At the end of this Monday, March 8, Cuba reports 1041 new cases of COVID-19 and two deaths, reported Dr. Francisco Duran Garcia, national director of Epidemiology of the Ministry of Public Health (Minsap).
At the end of this Tuesday, February 17, Cuba reported 824 new cases of COVID-19 and three deaths, as reported this Wednesday by Dr. Francisco Durán García, national director of Epidemiology of the Ministry of Public Health (Minsap).
In Cuba, more than 93% of the patients who have been infected with COVID-19 have recovered, a figure above the world average, which barely exceeds 69%; this reality shows how much has been done in the country in more than eight months of hard battle to save lives.
In Cuba, 2,280 patients are admitted for clinical epidemiological surveillance, 773 suspected, 1,077 under surveillance and 430 confirmed. For COVID-19, 8,203 samples were studied, resulting in 58 positive samples.